We are live on !
Find out more
WFG
Wormser Freres Gestion Portfolio holdings
AUM
$181M
Turnover
14.86%
1-Year Est. Return
17.24%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+17.24%
3 Year Est. Return
+67.36%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$3.74M
(+2.1%)
Cap. Flow
-$444K
Cap. Flow % of AUM
Cap. Flow %
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
61.37%
Holding
74
New
8
Increased
31
Reduced
20
Closed
3
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$4.36M |
| 2 |
Xylem
XYL
|
+$3.45M |
| 3 |
MSCI
MSCI
|
+$3.26M |
| 4 |
NVIDIA
NVDA
|
+$2.81M |
| 5 |
Vertiv
VRT
|
+$688K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$4.11M |
| 2 |
Cadence Design Systems
CDNS
|
+$3.93M |
| 3 |
Palo Alto Networks
PANW
|
+$3.51M |
| 4 |
Alcon
ALC
|
+$2.57M |
| 5 |
Amazon
AMZN
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.76% |
| 2 | Healthcare | 19.93% |
| 3 | Industrials | 11.96% |
| 4 | Financials | 10.3% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Zoetis
ZTS
$32.3B
| $45.5K | 0.03% |
651
-28
| -4% | -$2.09K |
2023 Q4
11 quarters
|
|
52
Danaher
DHR
$163B
| $42.8K | 0.02% |
193
-1,504
| -89% | -$309K |
2023 Q4
11 quarters
|
|
53
Illumina
ILMN
$42.2B
| $39.4K | 0.02% |
144
+39
| +37% | +$8.19K |
2023 Q4
11 quarters
|
|
54
Boston Scientific
BSX
$65.3B
| $28.9K | 0.02% |
661
+198
| +43% | +$9.17K |
2026 Q2
1 quarter
|
|
55
VanEck Agribusiness ETF
MOO
$1.1B
| $28.6K | 0.02% |
351
| – | – |
2023 Q4
11 quarters
|
|
56
Steris
STE
$22.3B
| $28.6K | 0.02% |
+136
| New | +$30.2K |
2026 Q3
0 quarters
|
|
57
UnitedHealth
UNH
$368B
| $23.9K | 0.01% |
65
| – | – |
2023 Q4
11 quarters
|
|
58
Snowflake
SNOW
$119B
| $22.8K | 0.01% |
67
+5
| +8% | +$1.54K |
2026 Q2
1 quarter
|
|
59
Fortinet
FTNT
$136B
| $22.7K | 0.01% |
127
+9
| +8% | +$1.46K |
2026 Q2
1 quarter
|
|
60
Datadog
DDOG
$101B
| $22.5K | 0.01% |
82
+18
| +28% | +$4.45K |
2026 Q2
1 quarter
|
|
61
Cloudflare
NET
$117B
| $22.2K | 0.01% |
64
-2
| -3% | -$592 |
2026 Q2
1 quarter
|
|
62
Intel
INTC
$496B
| $21K | 0.01% |
175
| – | – |
2023 Q4
11 quarters
|
|
63
Applied Materials
AMAT
$314B
| $20.5K | 0.01% |
40
-4
| -9% | -$2.03K |
2026 Q2
1 quarter
|
|
64
MongoDB
MDB
$31.4B
| $17.4K | 0.01% |
50
-1
| -2% | -$378 |
2026 Q2
1 quarter
|
|
65
Lumentum
LITE
$78.5B
| $16.5K | 0.01% |
17
+1
| +6% | +$846 |
2026 Q2
1 quarter
|
|
66
Credo Technology Group
CRDO
$31.5B
| $15K | 0.01% |
77
+6
| +8% | +$1.29K |
2026 Q2
1 quarter
|
|
67
Synopsys
SNPS
$90.9B
| $10K | 0.01% |
+23
| New | +$9.38K |
2026 Q3
0 quarters
|
|
68
Autodesk
ADSK
$50.6B
| $8.99K | 0.01% |
43
+15
| +54% | +$3.42K |
2026 Q2
1 quarter
|
|
69
Align Technology
ALGN
$10.8B
| $8.58K | ﹤0.01% |
59
| – | – |
2023 Q4
11 quarters
|
|
70
Teradyne
TER
$50.6B
| $8.42K | ﹤0.01% |
21
-15
| -42% | -$5.53K |
2026 Q2
1 quarter
|
|
71
Dynatrace
DT
$18.4B
| $3.29K | ﹤0.01% |
+57
| New | +$2.82K |
2026 Q3
0 quarters
|
|
72
Arm
ARM
$242B
| – | – |
-52
| Closed | -$18.4K | – |
|
73
Fair Isaac
FICO
$14.9B
| – | – |
-9
| Closed | -$10.8K | – |
|
74
KLA
KLAC
$201B
| – | – |
-3,576
| Closed | -$1M | – |
|
Similar funds
MIM
Wormser Freres Gestion's Q3 2026 Portfolio in Review
As of Q3 2026, Wormser Freres Gestion held 74 positions worth $181M, up 2.1% from $177M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Wormser Freres Gestion's Q3 2026 filing shows 8 new, 31 increased, 20 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 2,149 shares worth $351K. The largest sale was Thermo Fisher Scientific, an estimated $4.11M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Wormser Freres Gestion's largest Q3 2026 buy was AstraZeneca: 2,149 shares worth $351K.
- Wormser Freres Gestion added most to Lam Research in Q3 2026, an estimated $4.36M increase.
- Wormser Freres Gestion's biggest Q3 2026 reduction was Thermo Fisher Scientific, cutting an estimated $4.11M.
- Wormser Freres Gestion fully exited KLA in Q3 2026, selling an estimated $1M.
- Wormser Freres Gestion's ten largest holdings make up 61% of its $181M portfolio in Q3 2026.
- Wormser Freres Gestion opened 8 new positions and closed 3 in Q3 2026.
- Wormser Freres Gestion's portfolio value rose 2.1% quarter-over-quarter to $181M.
Based on Wormser Freres Gestion's 13F filing for Q3 2026, filed 21 Oct 2026.